FEB 27, 2019 8:00 AM PST

Prepare for success: GMP cell banks as part of a staged, standardized, platform-style cell production process

Speaker
  • CEO and Co-Founder of Pluristyx Inc.
    Biography
      Ben Fryer is the CEO and co-founder of Pluristyx Inc. providing GMP pre-expanded pluripotent stem cells, contract development services, and consultancy for groups and company developing cell and tissue therapies. Ben has almost 25 years of experience as a leader and scientist in large pharma, academia, and start-up companies developing combination products and cell therapies. He has worked to generate GMP/ clinical grade pluripotent stem cells from early banking through large scale expansion using scalable, closed-loop, suspension reactor processes to manufacture cell therapy treatments for diabetes and heart disease.

      Ben is an inventor on multiple issued patents and patent applications for BetaLogics/Janssen/ J&J, including a bioreactor based, stem cell suspension expansion and differentiation process and a product currently marketed by Thermo-Fisher(TM) as Nunclon-Vita.

      Ben earned his BA from Colorado College, his PhD from UPENN, and studied as a post-doctoral fellow in the Howard Hughes Laboratory of M. Celeste Simon at the University of Pennsylvania investigating the role of Hypoxia Inducible Factor in cancer and stem cell development.

    Abstract
    DATE:  February 27, 2019
    TIME:  8:00am PST
     
    Pluripotent stem cells (PSCs) can form any tissue or cell in the body, and are the ideal starting material to manufacture replacement organs and cellular therapies. Many groups have shown therapeutic proof-of-concept of PSC-derived cells or tissues in relevant animal models, but PSCs are still more of a promise than a reality because of manufacturing challenges.  The task of manufacturing a sufficient number of cells under Good Manufacturing Practices (GMP) to enable clinical trials and eventual commercialization is a substantial hurdle. Furthermore, all allogeneic therapies, including those derived from PSCs, must meet strict regulatory requirements. One such requirement is the need for extensive, costly characterization and safety testing of the parental cell line and the subsequent master and working cell banks (MCB/WCB). The time and expense required to complete this testing necessitates the MCB be of sufficient quality and size to meet not only the requirements of a Phase 1 regulatory filing (IND), but also for the lifetime of the product through late stage trials and commercialization. This presentation will focus on the “how and why” of integrating high quality ancillary raw materials into cell therapy product development and manufacturing workflow, beginning with the starting cell source and MCB.  Generation of a high-quality MCB is especially crucial for PSC-derived therapies because the first and most critically important step in product manufacturing is procurement of GMP-compliant starting material that meet regulatory requirements. Consequently, using high-quality raw materials from suppliers experienced in supporting cell therapy development and GMP manufacturing increase the probability of success and reduce the risk of costly surprises that could spell clinical or financial failure for a promising cell therapy product.  
     
    Learning Objectives:
    • Understand how and why cell banking is used for cell therapy manufacturing
    • Understand how and why to incorporate quality reagents and raw materials early in the development process
     
    Watch our related webinars here:
     
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
     

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    FEB 27, 2019 8:00 AM PST

    Prepare for success: GMP cell banks as part of a staged, standardized, platform-style cell production process


    Specialty

    Cell Biology

    Biotechnology

    Molecular Biology

    Cancer Research

    Clinical Research

    Immunology

    Cell Culture

    Genetics

    Laboratory Testing

    Molecular Diagnostics

    Medicine

    Clinical Diagnostics

    Drug Discovery

    Biochemistry

    Cancer Therapeutics

    Geography

    North America52%

    Europe20%

    Asia16%

    South America6%

    Africa4%

    Oceania1%

    Registration Source

    Website Visitors54%

    Email Promotions28%

    WAVE Newsletter Promotion11%

    Trending Newsletter Promotion2%

    Client/Sponsor Promotions2%

    Social Media Promotions1%

    Website Banners1%

    Other1%

    Job Title

    Research Scientist16%

    Facility/Department Manager14%

    Executive11%

    Student11%

    Scientist9%

    Medical Laboratory Technician8%

    Medical Doctor/Specialist5%

    Clinical Laboratory Scientist5%

    Educator/Faculty5%

    Consultant3%

    Lab Management3%

    QC/QA3%

    Post Doc2%

    Marketing/Sales2%

    Biologist2%

    Engineer1%

    Organization

    Academic Institution22%

    Biotech Company19%

    Hospital10%

    Clinical Laboratory6%

    Research Institute6%

    Life Science Company5%

    Consultant3%

    Pharmaceutical Company3%

    Manufacturer & Biotech/pharma3%

    Industrial Company3%

    Medical Center2%

    Medical School2%

    Government2%

    Contract Research Organization (Cro)2%

    Other4%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more